Apr 6, 2024, 07:42
Early-stage triple-negative breast cancer treated with locoregional therapy only – JAMA Oncology
JAMA Oncology shared on X/Twitter:
“In patients with early-stage triple-negative breast cancer treated with locoregional therapy only, higher levels of tumor-infiltrating lymphocytes in breast cancer tissue were associated with improved survival.”
Visit the article website.
Source: JAMA Oncology/X
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Oct 5, 2024, 03:07
Oct 5, 2024, 02:08
Oct 5, 2024, 02:01
Oct 5, 2024, 01:54
Oct 4, 2024, 19:20